[Congressional Record (Bound Edition), Volume 155 (2009), Part 15]
[Extensions of Remarks]
[Pages 20063-20064]
[From the U.S. Government Publishing Office, www.gpo.gov]




                          EARMARK DECLARATION

                                 ______
                                 

                           HON. PHIL GINGREY

                               of georgia

                    in the house of representatives

                        Wednesday, July 29, 2009

  Mr. GINGREY of Georgia. Madam Speaker, pursuant to the Republican 
Leadership standards on earmarks as well as in accordance with Clause 9 
of Rule XXI, I am submitting the following information regarding 
earmarks I received as part of H.R. 3326, the Department of Defense 
Appropriations Act, 2010.
  Requesting Member: Congressman Phil Gingrey
  Bill Number: H.R. 3326
  Account: Research, Development, Test, Evaluation, Army
  Legal Name of Requesting Entity: Georgia Institute of Technology
  Address of Requesting Entity: Institute of Bioengineering and 
Bioscience, 315 Ferst Drive, NW, Atlanta, Georgia 30332-0363
  Description of Request: The $3,000,000 included in H.R. 3326 for the 
Center for Advanced Bioengineering and Solider Survivability (CABSS) 
will focus on research in advanced tissue and bone regeneration and 
wound care and treatment issues relevant to military trauma care. 
Fundamental research advances in these areas can lead to technologies 
and techniques for better immediate clinical combat care as well as 
address long term care issues involving limb loss, tissue and organ 
damage, facial and dental injuries, and reconstruction.
  Specifically, the $3,000,000 in funding will be paid out at pre-
negotiated rates in accordance with Department of Defense policy. 
Specifically, funds will be used to: establish a seed grant program to 
identify novel technologies for treatment of musculoskeletal defects 
following trauma, develop oriented nano-fiber meshes for treatment of 
neurologic defects following injury to the extremities, develop 
biodegradable shape memory polymers for treatment of large bone 
defects, develop biodegradable shape memory polymers for craniofacial 
reconstruction, and test the effects of sustained delivery of 
osteoinductive proteins in tubular nanofiber mesh scaffolds on 
functional repair of large segmental bone defects.
  Georgia Tech will continue to leverage this request to obtain funding 
from other sources. The Georgia Research Alliance has pledged 
additional money to the project for infrastructure and equipment, and 
past Congressional funding has been leveraged to successfully obtain 
funding from DoD's Orthopaedic Trauma Research Program and its Armed 
Forces Institute of Regenerative Medicine, as well as funding from the 
Musculoskeletal Transplant Foundation.
  Requesting Member: Congressman Phil Gingrey
  Bill Number: H.R. 3326
  Account: Research, Development, Test, Evaluation, Army
  Legal Name of Requesting Entity: Printpack, Inc.
  Address of Requesting Entity: 2800 Overlook Drive NE, Atlanta, GA 
30345-2024
  Description of Request: The $1,000,000 added to H.R. 3326 will be 
used to develop new and innovative packaging and processing 
technologies for the Warfighter's combat rations. These funds will 
result in the ability to provide greater variety and more nutritional 
rations with longer shelf-life and reduced production costs.
  The objective of this effort is to develop advanced thermal 
processing techniques based on the utilization of non-foil materials 
for military ration packaging. The importance of developing non-foil 
packaging materials will serve as a precursor to the next stage of the 
R&D effort to investigate new and enhanced thermal processing 
techniques--specifically, Enhanced High Pressure Processing (EHPP) and 
Microwave Sterilization (MW) technologies. The EHPP and MW processing 
technologies have numerous advantages over

[[Page 20064]]

conventional thermal processing; however, these processes cannot be 
used on current foil packaging because they cause blistering and flex 
cracking of the foil packaging material. Therefore, to achieve the 
advantages of advanced EHPP and MW processing, it is essential to use 
state-of-the-art, non-foil packaging materials.
  The development of advanced, non-foil packaging materials and 
utilization of innovative EHPP and MW processing techniques will result 
in the provision of rations with the following beneficial and enhanced 
qualities: greater variety, better taste, more nutrition, longer shelf-
life, lower overall production costs, environmentally friendly, less 
volume and waste. The FY10 effort will consist of three stages and is 
budgeted as follows: Stage 1: Blistering ($0.14M), Stage 2: Flex Crack 
Resistance ($0.26M), Stage 3: EHPP & MW Trials ($0.6M).
  Requesting Member: Congressman Phil Gingrey
  Bill Number: H.R. 3326
  Account: Research, Development, Test, Evaluation, Defense Wide
  Legal Name of Requesting Entity: Scientific Research Corporation
  Address of Requesting Entity: 2300 Windy Ridge Parkway, Suite 400, 
Atlanta, GA 30339
  Description of Request: This program will utilize recently developed 
Wavelet Packet Modulation (WPM). The $1,000,000 included in H.R. 3326 
will be used to implement design modifications for limited rate initial 
production, including form factor packaging changes for ruggedization 
and for integration with signal intelligence systems. Additionally, 
production readiness for integration with existing communications 
systems will occur. Finally, module testing will be subjected to 
continued assessment and utility testing on multiple platforms.
  The enhanced modules will then undergo a final government Production 
Readiness Review, paving the way for subsequent deployment. Covert WPM 
Communications Modules as communications links for multiple platforms, 
including unmanned aerial systems, provide a critical solution to 
special operations warfighters that require the ability to communicate 
covertly without detection.
  Funding is required for hardware and software engineering, 
integration, and testing (64%); specialized equipment (21%); 
specialized software (13%); and travel to U.S. Special Operations 
Command and to military test sites (2%). This request is consistent 
with the intended and authorized purpose of the U.S. Special Operations 
Command Special Operations Tactical Systems Development program.
  Requesting Member: Congressman Phil Gingrey
  Bill Number: H.R. 3326
  Account: Other Procurement, Army
  Legal Name of Requesting Entity: Meggitt Training Systems
  Address of Requesting Entity: 7340 McGinnis Ferry Road, Suwanee, GA 
30024
  Description of Request: The ARNG combined arms simulation training 
system began in 1996, and presently there are 266 fielded Combat Skills 
Marksmanship Trainers (CSMT) systems. All have been or are in the 
process of being upgraded. The ARNG has an immediate requirement to 
supply its soldiers with newer and more advanced training technology, 
since simulators are an integral part of the training requirement. 
Since the Army no longer supports the ARNG with training simulator 
systems, Congress has consistently provided funding for these systems 
upgrades. ARNG itself has contributed funds of its own--$4.5 million in 
FY07 and $1.2 million in FY08.
  The ARNG's immediate need is to upgrade the remaining fleet of CSMT 
systems, and the plan includes acquiring approximately 1,200 new 
weapons. The $4,000,000 included in H.R. 3326 will continue the 
multiyear upgrade and modernization of existing firearms simulation 
systems in the Army National Guard necessary to meet the validated 
system standard.
  The ARNG has defined modernization as paramount to resolving an 
immediate mandatory small-arms training need in support of the Guard's 
role in a global war on terrorism and homeland security. The Army's 
Program Executive Office for Simulation, Training & Instrumentation 
(PEO STRI) has validated the upgraded system as a U.S. Army standard 
for use by the ARNG.
  The CSMT system includes U.S. Army-specific courseware and training 
scenarios that address new and complex tactical situations and provide 
soldiers with the ability to conduct weapons, judgmental, and military 
training in a tactical environment built on geo-specific terrain 
databases. The CSMT simulates tactical small unit defensive and 
offensive situations such as security operations, fire & maneuver, and 
hostage & clearing operations in built-urban areas. Small unit leaders 
use the system to conduct mission planning and rehearsal. The system's 
embedded scenario authoring capability allows the user to quickly 
author a scenario reflecting emerging doctrinal and/or mission 
requirement changes.
  Requesting Member: Congressman Phil Gingrey
  Bill Number: H.R. 3326
  Account: Research, Development, Test, Evaluation, Army
  Legal Name of Requesting Entity: CryoLife
  Address of Requesting Entity: 1655 Roberts Boulevard, NW, Kennesaw, 
GA 30144
  Description of Request: Despite advances in medical technology, 
battlefield trauma injuries present a significant threat to the lives 
of U.S. soldiers. In fact uncontrollable bleeding from internal wounds 
where tourniquets cannot be applied is a major cause of combat 
casualty. Biofoam Protein Hydrogel will provide a new tool for 
physicians to address blood loss at Forward Surgical Team (FST) and 
Combat Support Hospital (CSH) locations for injuries sustained by 
service personnel.
  CryoLife believes that further development of its existing protein 
hydrogel technology could result in FDA approval to address blood loss 
by forward surgical teams or combat support hospitals. CryoLife has 
developed a formulation for an expanding, adhesive, foam sealant. This 
two-part material is applied as a liquid that mixes in the portable 
delivery device and is expressed as a foam to the application site 
where it bends to the surrounding tissue. An easy to use, expandable 
hemostatic agent would provide better packing, faster hemostasis and 
improve the survival of the soldier by extending his ``golden hour.''
  Congress has appropriated $6.6 million for the development of this 
technology in FY05-09. The $1,000,000 included in H.R. 3326 will build 
upon the previously funded work conducted with the Army Medical 
Research and Material Command and the Army Institute of Surgical 
Research (ISR), including feasibility studies and acute and chronic 
animal studies. The funding included in H.R. 3326 would support large 
scale pivotal clinical trials on humans in accordance with FDA 
standards and protocols.

                          ____________________